References

Accurso, F. J., S. M. Rowe, J. P. Clancy, M. P. Boyle, J. M. Dunitz, P. R. Durie, S. D. Sagel, D. B. Hornick, M. W. Konstan, S. H. Donaldson, R. B. Moss, J. M. Pilewski, R. C. Rubenstein, A. Z. Uluer, M. L. Aitken, S. D. Freedman, L. M. Rose, N. Mayer-Hamblett, Q. Dong, J. Zha, A. J. Stone, E. R. Olson, C. L. Ordonez, P. W. Campbell, M. A. Ashlock, and B. W. Ramsey. 2010. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. New England Journal of Medicine 363(21):1991-2003.

ACMG (American College of Medical Genetic and Genomics). 2016. American College of Medical Genetics and Genomics Practice Guidelines. https://www.acmg.net/ACMG/Publications/Practice_Guidelines/ACMG/Publications/Practice_Guidelines.aspx (accessed December 21, 2016).

ACMG Board of Directors. 2015. Clinical utility of genetic and genomic services: A position statement of the American College of Medical Genetics and Genomics. Genetics in Medicine 17(6):505-507.

AHRQ (Agency for Healthcare Research and Quality). 2012. Methods guide for medical test reviews. AHRQ Publication No. 12-EHC017. Department of Health and Human Services. June 2016.

AHRQ. 2013. Evidence-based Practice Centers (EPC) Program overview. http://www.ahrq.gov/research/findings/evidence-based-reports/overview/index.html (accessed December 21, 2016).

AHRQ. 2014. Methods guide for effectiveness and comparative effectiveness reviews. AHRQ Publication No.: 10(14)-EHC063-EF. Washington, DC: Department of Health and Human Services.

Alldred, S. K., B. Guo, Y. Takwoingi, M. Pennant, S. Wisniewski, J. J. Deeks, J. P. Neilson, and Z. Alfirevic. 2015. Urine tests for Down’s syndrome screening. Cochrane Database of Systematic Reviews (12):CD011984.

Almannai, M., R. Marom, and V. R. Sutton. 2016. Newborn screening: A review of history, recent advancements, and future perspectives in the era of next generation sequencing. Current Opinions in Pediatrics 28(6):694-699.

Amendola, L. M., M. O. Dorschner, P. D. Robertson, J. S. Salama, R. Hart, B. H. Shirts, M. L. Murray, M. J. Tokita, C. J. Gallego, D. S. Kim, J. T. Bennett, D. R. Crosslin, J. Ranchalis, K. L. Jones, E. A. Rosenthal, E. R. Jarvik, A. Itsara, E. H. Turner, D. S. Herman, J. Schleit, A. Burt, S. M. Jamal, J. L. Abrudan, A. D. Johnson, L. K. Conlin, M. C. Dulik, A. Santani, D. R. Metterville, M. Kelly, A. K. Foreman, K. Lee, K. D. Taylor, X. Guo, K. Crooks, L. A. Kiedrowski, L. J. Raffel, O. Gordon, K. Machini, R. J. Desnick, L. G. Biesecker, S. A. Lubitz, S. Mulchandani, G. M. Cooper, S. Joffe, C. S. Richards, Y. Yang, J. I. Rotter, S. S. Rich, C. J. O’Donnell, J. S. Berg, N. B. Spinner, J. P. Evans, S. M. Fullerton, K. A. Leppig, R. L. Bennett, T. Bird, V. P. Sybert, W. M. Grady, H. K. Tabor, J. H. Kim, M. J. Bamshad, B. Wilfond, A. G. Motulsky, C. R. Scott, C. C. Pritchard, T. D. Walsh, W. Burke, W. H. Raskind, P. Byers, F. M. Hisama, H. Rehm, D. A. Nickerson, and G. P. Jarvik. 2015. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Research 25(3):305-315.

Anderson, J. L., B. D. Horne, S. M. Stevens, A. S. Grove, S. Barton, Z. P. Nicholas, S. F. Kahn, H. T. May, K. M. Samuelson, J. B. Muhlestein, and J. F. Carlquist. 2007. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Circulation 116(22):2563-2570.

Anderson, J. L., B. D. Horne, S. M. Stevens, S. C. Woller, K. M. Samuelson, J. W. Mansfield, M. Robinson, S. Barton, K. Brunisholz, C. P. Mower, J. A. Huntinghouse, J. S. Rollo, D. Siler, T. L. Bair, S. Knight, J. B. Muhlestein, and J. F. Carlquist. 2012. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Circulation 125(16):1997-2005.

Anderson, J. A., R. Z. Hayeems, C. Shuman, M. J. Szego, N. Monfared, S. Bowdin, R. Zlotnik Shaul, and M. S. Meyn. 2015. Predictive genetic testing for adult-onset disorders in minors: a critical analysis of the arguments for and against the 2013 ACMG guidelines. Clinical Genetics 87(4):301-310.

Andersson, R., C. Gebhard, I. Miguel-Escalada, I. Hoof, J. Bornholdt, M. Boyd, Y. Chen, X. Zhao, C. Schmidl, T. Suzuki, E. Ntini, E. Arner, E. Valen, K. Li, L. Schwarzfischer, D. Glatz, J. Raithel, B. Lilje, N. Rapin, F. O. Bagger, M. Jorgensen, P. R. Andersen, N. Bertin, O. Rackham, A. M. Burroughs, J. K. Baillie, Y. Ishizu, Y. Shimizu, E. Furuhata, S. Maeda, Y. Negishi, C. J. Mungall, T. F. Meehan, T. Lassmann, M. Itoh, H. Kawaji, N. Kondo, J. Kawai, A. Lennartsson, C. O. Daub, P. Heutink, D. A. Hume, T. H. Jensen, H. Suzuki, Y. Hayashizaki, F. Muller, A. R. Forrest, P. Carninci, M. Rehli, and A. Sandelin. 2014. An atlas of active enhancers across human cell types and tissues. Nature 507(7493):455-461.

Angrist, M., and L. Jamal. 2015. Living laboratory: Whole-genome sequencing as a learning healthcare enterprise. Clinical Genetics 87(4):311-318.

Antonarakis, S. E., and J. S. Beckmann. 2006. Mendelian disorders deserve more attention. Nature Reviews Genetics 7(4):277-282.

ASCO (American Society of Clinical Oncology). 2013a. ASCO Guidelines Methodology Manual—Figure 1 and Appendix 1. https://pilotguidelines.atlassian.net/wiki/display/GW/Guideline+Development+Process?preview=/8487049/21790726/Ratings%20of%20evidence%20and%20recs.pdf (accessed February 3, 2016).

ASCO. 2013b. Provisional Clinical Opinion: Policy and Procedures. https://pilotguidelines.atlassian.net/wiki/download/attachments/8487049/PCO%20Procedures.pdf?version=1&modificationDate=1389303567193&api=v2 (accessed September 27, 2016).

ASCO. 2015. ASCO Guidelines Methodology Manual. https://pilotguidelines.atlassian.net/wiki/display/GW/Guideline+Development+Process (accessed February 3, 2016).

Avery, O. T., C. M. Macleod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from Pneumococcus Type III. Journal of Experimental Medicine 79(2):137-158.

Beadle, G. W., and E. L. Tatum. 1941. Genetic control of biochemical reactions in neurospora. Proceedings of the National Academy of Sciences of the United States of America 27(11):499-506.

Behjati, S., and P. S. Tarpey. 2013. What is next generation sequencing? Archives of Disease in Childhood Education and Practice Edition 98(6):236-238.

Berg, J. S., and C. M. Powell. 2015. Potential uses and inherent challenges of using genome-scale sequencing to augment current newborn screening. Cold Spring Harbor Perspectives in Medicine 5(12):a023150.

Berg, J. S., L. M. Amendola, C. Eng, E. Van Allen, S. W. Gray, N. Wagle, H. L. Rehm, E. T. DeChene, M. C. Dulik, F. M. Hisama, W. Burke, N. B. Spinner, L. Garraway, R. C. Green, S. Plon, J. P. Evans, and G. P. Jarvik. 2013. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genetics in Medicine 15(11):860-867.

Berg, J. S., P. B. Agrawal, D. B. Bailey, Jr., A. H. Beggs, S. E. Brenner, A. M. Brower, J. A. Cakici, O. Ceyhan-Birsoy, K. Chan, F. Chen, R. J. Currier, D. Dukhovny, R. C. Green, J. Harris-Wai, I. A. Holm, B. Iglesias, G. Joseph, S. F. Kingsmore, B. A. Koenig, P. Y. Kwok, J. Lantos, S. J. Leeder, M. A. Lewis, A. L. McGuire, L. V. Milko, S. D. Mooney, R. B. Parad, S. Pereira, J. Petrikin, B. C. Powell, C. M. Powell, J. M. Puck, H. L. Rehm, N. Risch, M. Roche, J. T. Shieh, N. Veeraraghavan, M. S. Watson, L. Willig, T. W. Yu, T. Urv, and A. L. Wise. 2017. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics 139(2):e20162252.

Biesecker, L. G., and R. C. Green. 2014. Diagnostic clinical genome and exome sequencing. New England Journal of Medicine 371(12):1170.

BioReference Laboratories, Inc. 2016. GeneTests. https://www.genetests.org (accessed August 9, 2016).

Botkin, J. R., S. M. Teutsch, C. I. Kaye, M. Hayes, J. E. Haddow, L. A. Bradley, K. Szegda, W. D. Dotson, and E. W. Group. 2010. Outcomes of interest in evidence-based evaluations of genetic tests. Genetics in Medicine 12(4):228-235.

Broadstock, M., S. Michie, and T. Marteau. 2000. Psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics 8(10):731-738.

Brookes, A. J., and P. N. Robinson. 2015. Human genotype-phenotype databases: Aims, challenges and opportunities. Nature Reviews Genetics 16(12):702-715.

Brozek, J. L., E. A. Akl, P. Alonso-Coello, D. Lang, R. Jaeschke, J. W. Williams, B. Phillips, M. Lelgemann, A. Lethaby, J. Bousquet, G. H. Guyatt, H. J. Schunemann, and G. W. Group. 2009. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64(5):669-677.

Burke, W., A. H. Antommaria, R. Bennett, J. Botkin, E. W. Clayton, G. E. Henderson, I. A. Holm, G. P. Jarvik, M. J. Khoury, B. M. Knoppers, N. A. Press, L. F. Ross, M. A. Rothstein, H. Saal, W. R. Uhlmann, B. Wilfond, S. M. Wolf, and R. Zimmern. 2013. Recommendations for returning genomic incidental findings? We need to talk! Genetics in Medicine 15(11):854-859.

Burmester, J. K., R. L. Berg, S. H. Yale, C. M. Rottscheit, I. E. Glurich, J. R. Schmelzer, and M. D. Caldwell. 2011. A randomized controlled trial of genotype-based Coumadin initiation. Genetics in Medicine 13(6):509-518.

CAP (College of American Pathologists). 2015. Evidence-Based Guideline (EBG) Development and Review Process. http://www.cap.org/ShowProperty?nodePath=/UCMCon/Contribution%20Folders/WebContent/pdf/process-develop-evidence-based-guidelines.pdf (accessed September 27, 2016).

CAP. 2016. Proficiency Testing. http://www.cap.org/web/home/lab/proficiency-testing?_adf.ctrlstate=2zd8d3mce_67&_afrLoop=1346126263566917#!%40%40%3F_afrLoop%3D1346126263566917%26_adf.ctrl-state%3Dpv0uub3kl_4 (accessed September 27, 2016).

Carlson, A. C. 2004. Mendel’s legacy: The origin of classical genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.

Carvalho, C. M. B., and J. R. Lupski. 2016. Mechanisms underlying structural variant formation in genomic disorders. Nature Reviews Genetics 17(4):224-238.

Caudle, K. E., T. E. Klein, J. M. Hoffman, D. J. Müller, M. Whirl-Carrillo, L. Gong, E. M. McDonagh, K. Sangkuhl, C. F. Thorn, M. Schwab, J. A. Agúndez, R. R. Freimuth, V. Huser, M. T. M. Lee, O. F. Iwuchukwu, K. R. Crews, S. A. Scott, M. Wadelius, J. J. Swen, R. F. Tyndale, C. M. Stein, D. Roden, M. V. Relling, M. S. Williams, and S. G. Johnson. 2014. Incorporation of pharmacogenomics into routine clinical practice: The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process. Current Drug Metabolism 15(2):209-217.

CDC (Centers for Disease Control and Prevention). 2013. ACCE model list of 44 targeted questions aimed at comprehensive review of genetic testing. http://www.cdc.gov/genomics/gtesting/acce/acce_proj.htm (accessed February 3, 2016).

CDC. 2016. Public health genomics knowledge base (v1.2). Office of Public Health Genomics, Centers for Disease Control and Prevention, Department of Health and Human Services. https://phgkb.cdc.gov/GAPPKB/evidencer.do?Mysubmit=init&query=&Mysubmit=Search (accessed August 9, 2016).

CDC Diabetes Cost-Effectiveness Study Group. 1998. The cost-effectiveness of screening for type 2 diabetes. Journal of the American Medical Association 280(20):1757-1763.

Chen, S., and G. Parmigiani. 2007. Meta-Analysis of BRCA1 and BRCA2 Penetrance. Journal of Clinical Oncology 25(11):1329-1333.

Chial, H. 2008. Mendelian genetics: Patterns of inheritance and single-gene disorders. Nature Education 1(1):63.

Chong, J. X., K. J. Buckingham, S. N. Jhangiani, C. Boehm, N. Sobreira, J. D. Smith, T. M. Harrell, M. J. McMillin, W. Wiszniewski, T. Gambin, Z. H. Coban Akdemir, K. Doheny, A. F. Scott, D. Avramopoulos, A. Chakravarti, J. Hoover-Fong, D. Mathews, P. D. Witmer, H. Ling, K. Hetrick, L. Watkins, K. E. Patterson, F. Reinier, E. Blue, D. Muzny, M. Kircher, K. Bilguvar, F. Lopez-Giraldez, V. R. Sutton, H. K. Tabor, S. M. Leal, M. Gunel, S. Mane, R. A. Gibbs, E. Boerwinkle, A. Hamosh, J. Shendure, J. R. Lupski, R. P. Lifton, D. Valle, D. A. Nickerson, G. Centers for Mendelian, and M. J. Bamshad. 2015. The genetic basis of mendelian phenotypes: Discoveries, challenges, and opportunities. American Journal of Human Genetics 97(2):199-215.

Clayton, E. W. 2003. Ethical, legal, and social implications of genomic medicine. New England Journal of Medicine 349(6):562-569.

Collins, F. S. 2008. Retrospective: Victor A. McKusick (1921-2008). Science 321(5891):925.

Cooper, D. N., M. Krawczak, C. Polychronakos, C. Tyler-Smith, and H. Kehrer-Sawatzki. 2013. Where genotype is not predictive of phenotype: Towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Human Genetics 132(10):1077-1130.

Cummings, B. B., J. L. Marshall, T. Tukiainen, M. Lek, S. Donkervoort, A. R. Foley, V. Bolduc, L. Waddell, S. Sandaradura, G. L. O’Grady, E. Estrella, H. M. Reddy, F. Zhao, B. Weisburd, K. Karczewski, A. O’Donnell-Luria, D. Birnbaum, A. Sarkozy, Y. Hu, H. Gonorazky, K. Claeys, H. Joshi, A. Bournazos, E. Oates, R. Ghaoui, M. Davis, N. G. Laing, A. Topf, G. Consortium, A. Beggs, P. B. Kang, K. N. North, V. Straub, J. Dowling, F. Muntoni, N. F. Clarke, S. T. Cooper, C. G. Bonnemann, and D. G. MacArthur. 2016. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. bioRxiv. http://biorxiv.org/content/early/2016/09/09/074153 (accessed January 31, 2017).

David, S. P., S. G. Johnson, A. C. Berger, W. G. Feero, S. F. Terry, L. A. Green, R. L. Phillips, Jr., and G. S. Ginsburg. 2015. Making personalized health care even more personalized: Insights from activities of the IOM Genomics Roundtable. Annals of Family Medicine 13(4):373-380.

DoD (Department of Defense). 2015. TRICARE Operationa Manual 6010.56-M. Chapter 18, Section 17: Defence Health Agency (DHA) evaluation of non-United States Food and Drug Administration (FDA) approved laboratory developed tests (LDTs) demonstration project. C-153.

Dondorp, W., G. de Wert, Y. Bombard, D. W. Bianchi, C. Bergmann, P. Borry, L. S. Chitty, F. Fellmann, F. Forzano, A. Hall, L. Henneman, H. C. Howard, A. Lucassen, K. Ormond, B. Peterlin, D. Radojkovic, W. Rogowski, M. Soller, A. Tibben, L. Tranebjaerg, C. G. van El, and M. C. Cornel. 2015. Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening. European Journal of Human Genetetics 23(11):1438-1450.

Dotson, W. D., M. S. Bowen, K. Kolor, and M. J. Khoury. 2016. Clinical utility of genetic and genomic services: Context matters. Genetics in Medicine 18(7):672-674.

Dunn, L. C. 1965. A short history of genetics; The development of some of the main lines of thought: 1864-1939. New York, Toronto: McGraw-Hill.

Dwan, K., C. Gamble, P. R. Williamson, and J. J. Kirkham. 2013. Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review. PLoS ONE 8(7):e66844.

Edwards, J. G., G. Feldman, J. Goldberg, A. R. Gregg, M. E. Norton, N. C. Rose, A. Schneider, K. Stoll, R. Wapner, and M. S. Watson. 2015. Expanded carrier screening in reproductive medicine-points to consider: A joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstetrics and Gynecology 125(3):653-662.

EGAPP (Evaluation of Genomic Applications in Practice and Prevention Working Group). 2007. Recommendations from the EGAPP Working Group: Testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genetics in Medicine 9(12):819-825.

EGAPP. 2009a. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genetics in Medicine 11(1):35-41.

EGAPP. 2009b. Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Genetics in Medicine 11(1):15-20.

EGAPP. 2009c. Recommendations from the EGAPP Working Group: Can tumor gene expression profiling improve outcomes in patients with breast cancer? Genetics in Medicine 11(1):66-73.

EGAPP. 2010. Recommendations from the EGAPP Working Group: Genomic profiling to assess cardiovascular risk to improve cardiovascular health. Genetics in Medicine 12(12):839-843.

EGAPP. 2011. Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genetics in Medicine 13(1):67-76.

EGAPP. 2013a. Recommendations from the EGAPP Working Group: Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy? Genetics in Medicine 15(7):517-527.

EGAPP. 2013b. Recommendations from the EGAPP Working Group: Does genomic profiling to assess type 2 diabetes risk improve health outcomes? Genetics in Medicine 15(8):612-617.

EGAPP. 2014a. The EGAPP initiative: Lessons learned. Genetics in Medicine 16(3):217-224.

EGAPP. 2014b. Recommendations from the EGAPP Working Group: Does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? Genetics in Medicine 16(4):338-346.

EGAPP. 2015. Recommendations from the EGAPP Working Group: Does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? Genetics in Medicine 18(8):770-779.

ENCODE Project Consortium. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57-74.

Ende, J., L. Kazis, A. Ash, and M. A. Moskowitz. 1989. Measuring patients’ desire for autonomy: Decision making and information-seeking preferences among medical patients. Journal of General Internal Medicine 4(1):23-30.

Evans, J. P., J. S. Berg, A. F. Olshan, T. Magnuson, and B. K. Rimer. 2013. We screen newborns, don’t we?: Realizing the promise of public health genomics. Genetics in Medicine 15(5):332-334.

FDA (Food and Drug Administration). 2014. In vitro companion diagnostic devices: Guidance for industry, Food and Drug Administration staff. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation, Research Center for Drug Evaluation and Research. http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm262327.pdf (accessed November 9, 2016).

FDA. 2016a. PrecisionFDA: Consistency challenge. https://precision.fda.gov/challenges/consistency (accessed August 18, 2016).

FDA. 2016b. List of cleared or approved companion diagnostic devices (in vitro and imaging tools). Department of Health and Human Services. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm (accessed September 27, 2016).

FDA. 2016c. Nucleic acids based tests. Department of Health and Human Services. www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm330711.htm (accessed September 27, 2016).

FDA. 2016d. Use of standards in FDA regulatory oversight of next generation sequencing (NGS)-based in vitro diagnostics (IVDs) used for diagnosing germline diseases: Draft guidance for stakeholders and Food and Drug Administration staff. Department of Health and Human Services. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM509838.pdf (accessed September 27, 2016).

FDA. 2016e. Use of public human genetic variant databases to support clinical validity for next generation sequencing (NGS)-based in vitro diagnostics: Draft guidance for stakeholders and Food and Drug Administration staff. Department of Health and Human Services. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-meddev-gen/documents/document/ucm509837.pdf (accessed November 9, 2016).

Feero, W. G., C. Wicklund, and D. L. Veenstra. 2013. The economics of genomic medicine: Insights from the IOM Roundtable on Translating Genomic-Based Research for Health. Journal of the American Medical Association 309(12):1235-1236.

Ferreira, P. H., M. L. Ferreira, C. G. Maher, K. Refshauge, R. D. Herbert, and J. Latimer. 2002. Effect of applying different “levels of evidence” criteria on conclusions of Cochrane reviews of interventions for low back pain. Journal of Clinical Epidemiology 55(11):1126-1129.

Fohner, A. E., R. Robinson, J. Yracheta, D. A. Dillard, B. Schilling, B. Khan, S. Hopkins, B. B. Boyer, J. Black, H. Wiener, H. K. Tiwari, A. Gordon, D. Nickerson, J. M. Tsai, F. M. Farin, T. A. Thornton, A. E. Rettie, and K. E. Thummel. 2015. Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX. Pharmacogenetics and Genomics 25(7):343-353.

Foster, M. W., J. J. Mulvihill, and R. R. Sharp. 2009. Evaluating the utility of personal genomic information. Genetics in Medicine 11(8):570-574.

Friedman, E. 2015. Next generation sequencing for newborn screening: Are we there yet? Genetic Research (Camb) 97:e17.

Frueh, F. W. 2013. Regulation, reimbursement, and the long road of implementation of personalized medicine—A perspective from the United States. Value Health 16(6 Suppl):S27-S31.

Frueh, F. W., and B. Quinn. 2014. Molecular diagnostics clinical utility strategy: A six-part framework. Expert Review of Molecular Diagnostics 14(7):777-786.

Fryback, D. G., and J. R. Thornbury. 1991. The efficacy of diagnostic imaging. Medical Decision Making 11(2):88-94.

Gargis, A. S., L. Kalman, M. W. Berry, D. P. Bick, D. P. Dimmock, T. Hambuch, F. Lu, E. Lyon, K. V. Voelkerding, B. A. Zehnbauer, R. Agarwala, S. F. Bennett, B. Chen, E. L. H. Chin, J. G. Compton, S. Das, D. H. Farkas, M. J. Ferber, B. H. Funke, M. R. Furtado, L. M. Ganova-Raeva, U. Geigenmüller, S. J. Gunselman, M. R. Hegde, P. L. F. Johnson, A. Kasarskis, S. Kulkarni, T. Lenk, C. S. J. Liu, M. Manion, T. A. Manolio, E. R. Mardis, J. D. Merker, M. S. Rajeevan, M. G. Reese, H. L. Rehm, B. B. Simen, J. M. Yeakley, J. M. Zook, and I. M. Lubin. 2012. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nature Biotechnology 30(11):1033-1036.

Garrod, A. E. 1996. The incidence of alkaptonuria: A study in chemical individuality. 1902. Molecular Medicine 2(3):274-282.

Gayán, J., D. Brocklebank, J. M. Andresen, G. Alkorta-Aranburu, U. S.-V. C. R. Group, M. Zameel Cader, S. A. Roberts, S. S. Cherny, N. S. Wexler, L. R. Cardon, and D. E. Housman. 2008. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington’s disease in the Venezuelan HD kindreds. Genetics in Epidemiology 32(5):445-453.

Gécz, J., C. Shoubridge, and M. Corbett. 2009. The genetic landscape of intellectual disability arising from chromosome X. Trends in Genetics 25(7):308-316.

Geneletti, S., V. Gallo, M. Porta, M. J. Khoury, and P. Vineis. 2011. Assessing causal relationships in genomics: From Bradford-Hill criteria to complex gene-environment interactions and directed acyclic graphs. Emerging Themes in Epidemiology 8(1):5.

Giacomini, M., F. Miller, and G. Browman. 2003. Confronting the “gray zones” of technology assessment: Evaluating genetic testing services for public insurance coverage in Canada. International Journal of Technology Assessment in Health Care 19(2):301-316.

Goddard, K. A., W. A. Knaus, E. Whitlock, G. H. Lyman, H. S. Feigelson, S. D. Schully, S. Ramsey, S. Tunis, A. N. Freedman, M. J. Khoury, and D. L. Veenstra. 2012. Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genetics in Medicine 14(7):633-642.

Graf, M. D., D. F. Needham, N. Teed, and T. Brown. 2013. Genetic testing insurance coverage trends: A review of publicly available policies from the largest US payers. Personalized Medicine 10(3):235-243.

Green, R. C., J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf, C. L. Martin, A. L. McGuire, R. L. Nussbaum, J. M. O’Daniel, K. E. Ormond, H. L. Rehm, M. S. Watson, M. S. Williams, L. G. Biesecker, G. American College of Medical, and Genomics. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine 15(7):565-574.

Green, R. C., D. Lautenbach, and A. L. McGuire. 2015. GINA, genetic discrimination, and genomic medicine. New England Journal of Medicine 372(5):397-399.

Green, R. C., K. A. Goddard, G. P. Jarvik, L. M. Amendola, P. S. Appelbaum, J. S. Berg, B. A. Bernhardt, L. G. Biesecker, S. Biswas, C. L. Blout, K. M. Bowling, K. B. Brothers, W. Burke, C. F. Caga-Anan, A. M. Chinnaiyan, W. K. Chung, E. W. Clayton, G. M. Cooper, K. East, J. P. Evans, S. M. Fullerton, L. A. Garraway, J. R. Garrett, S. W. Gray, G. E. Henderson, L. A. Hindorff, I. A. Holm, M. H. Lewis, C. M. Hutter, P. A. Janne, S. Joffe, D. Kaufman, B. M. Knoppers, B. A. Koenig, I. D. Krantz, T. A. Manolio, L. McCullough, J. McEwen, A. McGuire, D. Muzny, R. M. Myers, D. A. Nickerson, J. Ou, D. W. Parsons, G. M. Petersen, S. E. Plon, H. L. Rehm, J. S. Roberts, D. Robinson, J. S. Salama, S. Scollon, R. R. Sharp, B. Shirts, N. B. Spinner, H. K. Tabor, P. Tarczy-Hornoch, D. L. Veenstra, N. Wagle, K. Weck, B. S. Wilfond, K. Wilhelmsen, S. M. Wolf, J. Wynn, J. H. Yu, and C. Consortium. 2016. Clinical Sequencing Exploratory Research Consortium: Accelerating evidence-based practice of genomic medicine. American Journal of Human Genetics 98(6):1051-1066.

Griffiths, A. J. F., J. H. Miller, D. T. Suzuki, et al. 2000. An Introduction to Genetic Analysis. 7th ed. New York: W.H. Freeman. https://www.ncbi.nlm.nih.gov/books/NBK21830 (accessed November 9, 2016).

Gross, S. J., B. A. Pletcher, K. G. Monaghan, Professional Practice and Guidelines Committee. 2008. Carrier screening in individuals of Ashkenazi Jewish descent. Genetics in Medicine 10(1):54-56.

Grosse, S. D., and M. J. Khoury. 2006. What is the clinical utility of genetic testing? Genetics in Medicine 8(7):448-450.

Grosse, S. D., S. Wordsworth, and K. Payne. 2008. Economic methods for valuing the outcomes of genetic testing: Beyond cost-effectiveness analysis. Genetics in Medicine 10(9):648-654.

Guttmacher, A. E., and F. S. Collins 2002. Genomic medicine—a primer. New England Journal of Medicine 347(19):1512-1520.

Guyatt, G. H., A. D. Oxman, R. Kunz, Y. Falck-Ytter, G. E. Vist, A. Liberati, and H. J. Schunemann. 2008. Going from evidence to recommendations. British Medical Journal 336(7652):1049-1051.

Guyatt, G. H., A. D. Oxman, H. J. Schunemann, P. Tugwell, and A. Knottnerus. 2011. GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology 64(4):380-382.

Guyatt, G., J. W. Eikelboom, E. A. Akl, M. Crowther, D. Gutterman, S. R. Kahn, H. Schunemann, and J. Hirsh. 2013. A guide to GRADE guidelines for the readers of JTH. Journal of Thrombosis and Haemostasis 11(8):1603-1608.

Guzauskas, G. F., L. P. Garrison, J. Stock, S. Au, D. L. Doyle, and D. L. Veenstra. 2013. Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy. Genetics in Medicine 15(1):84-87.

Gwinn, M., J. P. Ioannidis, J. Little, and M. J. Khoury. 2014. Editorial: Updated guidance on Human Genome Epidemiology (HuGE) reviews and meta-analyses of genetic associations. American Journal of Epidemiology 180(6):559-561.

Haddow, J. E., and G. E. Palomaki. 2003. ACCE: A model process for evaluating data on emerging genetic tests. In Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease, edited by M. Khoury, J. Little, and W. Burke. New York: Oxford University Press. Pp. 217-233.

Haga, S. B., and J. Moaddeb. 2014. Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenetics and Genomics 24(3):139-145.

Hall, M., and O. I. Olopade. 2005. Confronting genetic testing disparities: Knowledge is power. Journal of the American Medical Association 293(14):1783-1785.

Harris, L. N., N. Ismaila, L. M. McShane, F. Andre, D. E. Collyar, A. M. Gonzalez-Angulo, E. H. Hammond, N. M. Kuderer, M. C. Liu, R. G. Mennel, C. Van Poznak, R. C. Bast, and D. F. Hayes. 2016. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology 34(10):1134-1150.

Harrison, S. M., E. R. Riggs, D. R. Maglott, J. M. Lee, D. R. Azzariti, A. Niehaus, E. M. Ramos, C. L. Martin, M. J. Landrum, and H. L. Rehm. 2016. Using ClinVar as a Resource to Support Variant Interpretation. Current Protocols in Human Genetics 89:8.16.11-18.16.23.

Hays, R. D., R. L. Kravitz, R. M. Mazel, C. D. Sherbourne, M. R. DiMatteo, W. H. Rogers, and S. Greenfield. 1994. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. Journal of Behavior Medicine 17(4):347-360.

Helbig, I., I. E. Scheffer, J. C. Mulley, and S. F. Berkovic. 2008. Navigating the channels and beyond: Unravelling the genetics of the epilepsies. The Lancet Neurology 7(3):231-245.

Heshka, J. T., C. Palleschi, H. Howley, B. Wilson, and P. S. Wells. 2008. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in Medicine 10(1):19-32.

Higgins, J. P. T., and S. Green (Eds.). 2011. Cochrane handbook for systematic reviews of interventions, Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. www.handbook.cochrane.org (accessed January 31, 2017).

Hilgart, J. S., B. Coles, and R. Iredale. 2012. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database of Systematic Reviews 2(2):CD003721.

Horne, R., S. C. Chapman, R. Parham, N. Freemantle, A. Forbes, and V. Cooper. 2013. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS ONE 8(12):e80633.

Hresko, A., and S. B. Haga. 2012. Insurance coverage policies for personalized medicine. Journal of Personalized Medicine 2(4):201-216.

Hunink, M. G. M., M. C. Weinstein, E. Wittenberg, M. F. Drummond, J. S. Pliskin, J. B. Wong, and P. P. Glasziou. 2014. Decision making in health and medicine: Integrating evidence and values. 2nd ed. Cambridge, UK: Cambridge University Press.

Hussein, N., S. F. Weng, J. Kai, J. Kleijnen, and N. Qureshi. 2015. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease. Cochrane Database of Systematic Reviews 8(8):CD010849.

Incollingo, B. F. 2014. How test reimbursement decisions are made: A leader of Medicare’s MolDX Program discusses evaluation process. OncLive. October 21, 2014. http://www.onclive.com/publications/urologists-in-cancer-care/2014/october-2014/how-test-reimbursement-decisions-are-made-a-leader-of-medicares-moldx-program-discusses-evaluation-process (accessed December 21, 2016).

Ioannidis, J. P., M. R. Munafo, P. Fusar-Poli, B. A. Nosek, and S. P. David. 2014. Publication and other reporting biases in cognitive sciences: Detection, prevalence, and prevention. Trends in Cognitive Science 18(5):235-241.

IOM (Institute of Medicine). 2011a. Finding what works in health care: Standards for systematic reviews. Washington, DC: The National Academies Press.

IOM. 2011b. Generating evidence for genomic diagnostic test development: Workshop summary. Washington, DC: The National Academies Press.

IOM. 2011c. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press.

IOM. 2015. Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies: Workshop summary. Washington, DC: The National Academies Press.

Jacob, F., and J. Monod. 1961. Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology 3:318-356.

Jacobson, T. A., M. K. Ito, K. C. Maki, C. E. Orringer, H. E. Bays, P. H. Jones, J. M. McKenney, S. M. Grundy, E. A. Gill, R. A. Wild, D. P. Wilson, and W. V. Brown. 2014. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1—executive summary. Journal of Clinical Lipidology 8(5):473-488.

Jimenez-Sanchez, G., B. Childs, and D. Valle. 2001. Human disease genes. Nature 409(6822):853-855. Johannsen, W. 1909. Elemente der exakten Erblichkeitslehre. Jena: Gustav Fischer.

Johansen Taber, K. A., B. D. Dickinson, and M. Wilson. 2014. The promise and challenges of next-generation genome sequencing for clinical care. JAMA Internal Mededicine 174(2):275-280.

Jonas, D. E., T. J. Wilt, B. C. Taylor, T. M. Wilkins, and D. B. Matchar. 2012. Chapter 11: Challenges in and principles for conducting systematic reviews of genetic tests used as predictive indicators. Journal of General Internal Medicine 27:S83-S93.

Jurgens, J., H. Ling, K. Hetrick, E. Pugh, F. Schiettecatte, K. Doheny, A. Hamosh, D. Avramopoulos, D. Valle, and N. Sobreira. 2015. Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics. Genetics in Medicine 17(10):782-788.

Kalia, S. S., K. Adelman, S. J. Bale, W. K. Chung, C. Eng, J. P. Evans, G. E. Herman, S. B. Hufnagel, T. E. Klein, B. R. Korf, K. D. McKelvey, K. E. Ormond, C. S. Richards, C. N. Vlangos, M. Watson, C. L. Martin, D. T. Miller, and the ACMG Secondary Findings Maintenance Working Group. 2016. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine (advance online publication November 17, 2016, doi: 10.1038/gim.2016.190).

Kay, C., J. A. Collins, Z. Miedzybrodzka, S. J. Madore, E. S. Gordon, N. Gerry, M. Davidson, R. A. Slama, M. and R. Hayden. 2016. Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology 87(3):282-288.

Kellis, M., B. Wold, M. P. Snyder, B. E. Bernstein, A. Kundaje, G. K. Marinov, L. D. Ward, E. Birney, G. E. Crawford, J. Dekker, I. Dunham, L. L. Elnitski, P. J. Farnham, E. A. Feingold, M. Gerstein, M. C. Giddings, D. M. Gilbert, T. R. Gingeras, E. D. Green, R. Guigo, T. Hubbard, J. Kent, J. D. Lieb, R. M. Myers, M. J. Pazin, B. Ren, J. A. Stamatoyannopoulos, Z. Weng, K. P. White, and R. C. Hardison. 2014. Defining functional DNA elements in the human genome. Procedings of the National Academy of Sciences of the United States of America 111(17):6131-6138.

Kemper, A. R., N. S. Green, N. Calonge, W. K. K. Lam, A. M. Comeau, A. J. Goldenberg, J. Ojodu, L. A. Prosser, S. Tanksley, and J. A. Bocchini Jr. 2014. Decision-making process for conditions nominated to the Recommended Uniform Screening Panel: Statement of the US Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Genetics in Medicine 16(2):183-187.

Kerns, S. L., S. Kundu, J. H. Oh, S. K. Singhal, M. Janelsins, L. B. Travis, J. O. Deasy, A. C. Janssens, H. Ostrer, M. Parliament, N. Usmani, and B. S. Rosenstein. 2015. The prediction of radiotherapy toxicity using single nucleotide polymorphism-based models: A step toward prevention. Seminars in Radiation Oncology 25(4):281-291.

Khera, A. V., C. A. Emdin, I. Drake, P. Natarajan, A. G. Bick, N. R. Cook, D. I. Chasman, U. Baber, R. Mehran, D. J. Rader, V. Fuster, E. Boerwinkle, O. Melander, M. Orho-Melander, P. M. Ridker, and S. Kathiresan. 2016. Genetic risk, adherence to a healthy lifestyle, and coronary disease. New England Journal of Medicine 375(24):2349-2358.

Khoury, M. J., R. J. Coates, and J. P. Evans. 2010. Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence. Genetics in Medicine 12(11):680-683.

Khoury, M. J., A. C. Janssens, and D. F. Ransohoff. 2013. How can polygenic inheritance be used in population screening for common diseases? Genetics in Medicine 15(6):437-443.

King, M. C., J. H. Marks, and J. B. Mandell. 2003. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646.

King, M. C., E. Levy-Lahad, and A. Lahad. 2014. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. Journal of the American Medical Association 312(11):1091-1092.

Kircher, M., D. M. Witten, P. Jain, B. J. O’Roak, G. M. Cooper, and J. Shendure. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nature Genetics 46(3):310-315.

Kohler, R. E. 1994. Lords of the fly: Drosophila genetics and the experimental life. Chicago: University of Chicago Press.

Krieger, J. L., F. Murray, J. S. Roberts, and R. C. Green. 2016. The impact of personal genomics on risk perceptions and medical decision-making. Nature Biotechnology 34(9):912-918.

Kuntz, K., F. Sainfort, M. Butler, B. Taylor, S. Kulasingam, S. Gregory, E. Mann, J. M. Anderson, and R. L. Kane. 2013. Decision and Simulation Modeling in Systematic Reviews: Overview of Decision Models Used in Research. Rockville (MD): Agency for Healthcare Research and Quality (US). https://www.ncbi.nlm.nih.gov/books/NBK127474 (accessed November 9, 2016).

Kwon, J. M., and A. M. Goate. 2000. The candidate gene approach. Alcohol Research & Health 24(3):164-168.

Lander, E. S., L. M. Linton, B. Birren, C. Nusbaum, M. C. Zody, J. Baldwin, K. Devon, K. Dewar, M. Doyle, W. FitzHugh, R. Funke, D. Gage, K. Harris, A. Heaford, J. Howland, L. Kann, J. Lehoczky, R. LeVine, P. McEwan, K. McKernan, J. Meldrim, J. P. Mesirov, C. Miranda, W. Morris, J. Naylor, C. Raymond, M. Rosetti, R. Santos, A. Sheridan, C. Sougnez, Y. Stange-Thomann, N. Stojanovic, A. Subramanian, D. Wyman, J. Rogers, J. Sulston, R. Ainscough, S. Beck, D. Bentley, J. Burton, C. Clee, N. Carter, A. Coulson, R. Deadman, P. Deloukas, A. Dunham, I. Dunham, R. Durbin, L. French, D. Grafham, S. Gregory, T. Hubbard, S. Humphray, A. Hunt, M. Jones, C. Lloyd, A. McMurray, L. Matthews, S. Mercer, S. Milne, J. C. Mullikin, A. Mungall, R. Plumb, M. Ross, R. Shownkeen, S. Sims, R. H. Waterston, R. K. Wilson, L. W. Hillier, J. D. McPherson, M. A. Marra, E. R. Mardis, L. A. Fulton, A. T. Chinwalla, K. H. Pepin, W. R. Gish, S. L. Chissoe, M. C. Wendl, K. D. Delehaunty, T. L. Miner, A. Delehaunty, J. B. Kramer, L. L. Cook, R. S. Fulton, D. L. Johnson, P. J. Minx, S. W. Clifton, T. Hawkins, E. Branscomb, P. Predki, P. Richardson, S. Wenning, T. Slezak, N. Doggett, J. F. Cheng, A. Olsen, S. Lucas, C. Elkin, E. Uberbacher, M. Frazier, R. A. Gibbs, D. M. Muzny, S. E. Scherer, J. B. Bouck, E. J. Sodergren, K. C. Worley, C. M. Rives, J. H. Gorrell, M. L. Metzker, S. L. Naylor, R. S. Kucherlapati, D. L. Nelson, G. M. Weinstock, Y. Sakaki, A. Fujiyama, M. Hattori, T. Yada, A. Toyoda, T. Itoh, C. Kawagoe, H. Watanabe, Y. Totoki, T. Taylor, J. Weissenbach, R. Heilig, W. Saurin, F. Artiguenave, P. Brottier, T. Bruls, E. Pelletier, C. Robert, P. Wincker, D. R. Smith, L. Doucette-Stamm, M. Rubenfield, K. Weinstock, H. M. Lee, J. Dubois, A. Rosenthal, M. Platzer, G. Nyakatura, S. Taudien, A. Rump, H. Yang, J. Yu, J. Wang, G. Huang, J. Gu, L. Hood, L. Rowen, A. Madan, S. Qin, R. W. Davis, N. A. Federspiel, A. P. Abola, M. J. Proctor, R. M. Myers, J. Schmutz, M. Dickson, J. Grimwood, D. R. Cox, M. V. Olson, R. Kaul, C. Raymond, N. Shimizu, K. Kawasaki, S. Minoshima, G. A. Evans, M. Athanasiou, R. Schultz, B. A. Roe, F. Chen, H. Pan, J. Ramser, H. Lehrach, R. Reinhardt, W. R. McCombie, M. de la Bastide, N. Dedhia, H. Blocker, K. Hornischer, G. Nordsiek, R. Agarwala, L. Aravind, J. A. Bailey, A. Bateman, S. Batzoglou, E. Birney, P. Bork, D. G. Brown, C. B. Burge, L. Cerutti, H. C. Chen, D. Church, M. Clamp, R. R. Copley, T. Doerks, S. R. Eddy, E. E. Eichler, T. S. Furey, J. Galagan, J. G. Gilbert, C. Harmon, Y. Hayashizaki, D. Haussler, H. Hermjakob, K. Hokamp, W. Jang, L. S. Johnson, T. A. Jones, S. Kasif, A. Kaspryzk, S. Kennedy, W. J. Kent, P. Kitts, E. V. Koonin, I. Korf, D. Kulp, D. Lancet, T. M. Lowe, A. McLysaght, T. Mikkelsen, J. V. Moran, N. Mulder, V. J. Pollara, C. P. Ponting, G. Schuler, J. Schultz, G. Slater, A. F. Smit, E. Stupka, J. Szustakowki, D. Thierry-Mieg, J. Thierry-Mieg, L. Wagner, J. Wallis, R. Wheeler, A. Williams, Y. I. Wolf, K. H. Wolfe, S. P. Yang, R. F. Yeh, F. Collins, M. S. Guyer, J. Peterson, A. Felsenfeld, K. A. Wetterstrand, A. Patrinos, M. J. Morgan, P. de Jong, J. J. Catanese, K. Osoegawa, H. Shizuya, S. Choi, Y. J. Chen, and J. Szustakowki. 2001. Initial sequencing and analysis of the human genome. Nature 409(6822):860-921.

Landrum, M. J., J. M. Lee, M. Benson, G. Brown, C. Chao, S. Chitipiralla, B. Gu, J. Hart, D. Hoffman, J. Hoover, W. Jang, K. Katz, M. Ovetsky, G. Riley, A. Sethi, R. Tully, R. Villamarin-Salomon, W. Rubinstein, and D. R. Maglott. 2016. ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Research 44(D1):D862-D868.

Lautenbach, D. M., K. D. Christensen, J. A. Sparks, and R. C. Green. 2013. Communicating genetic risk information for common disorders in the era of genomic medicine. Annual Review of Genomics and Human Genetics 14:491-513.

Lek, M., K. J. Karczewski, E. V. Minikel, K. E. Samocha, E. Banks, T. Fennell, A. H. O’Donnell-Luria, J. S. Ware, A. J. Hill, B. B. Cummings, T. Tukiainen, D. P. Birnbaum, J. A. Kosmicki, L. E. Duncan, K. Estrada, F. Zhao, J. Zou, E. Pierce-Hoffman, J. Berghout, D. N. Cooper, N. Deflaux, M. DePristo, R. Do, J. Flannick, M. Fromer, L. Gauthier, J. Goldstein, N. Gupta, D. Howrigan, A. Kiezun, M. I. Kurki, A. L. Moonshine, P. Natarajan, L. Orozco, G. M. Peloso, R. Poplin, M. A. Rivas, V. Ruano-Rubio, S. A. Rose, D. M. Ruderfer, K. Shakir, P. D. Stenson, C. Stevens, B. P. Thomas, G. Tiao, M. T. Tusie-Luna, B. Weisburd, H.-H. Won, D. Yu, D. M. Altshuler, D. Ardissino, M. Boehnke, J. Danesh, S. Donnelly, R. Elosua, J. C. Florez, S. B. Gabriel, G. Getz, S. J. Glatt, C. M. Hultman, S. Kathiresan, M. Laakso, S. McCarroll, M. I. McCarthy, D. McGovern, R. McPherson, B. M. Neale, A.

Palotie, S. M. Purcell, D. Saleheen, J. M. Scharf, P. Sklar, P. F. Sullivan, J. Tuomilehto, M. T. Tsuang, H. C. Watkins, J. G. Wilson, M. J. Daly, D. G. MacArthur, and C. Exome Aggregation. 2016. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285-291.

Little, J., and J. P. T. Higgins (Eds.). 2006. The HuGENet™ HuGE review handbook, version 1.0. http://www.hugenet.ca (accessed January 31, 2017).

Loblaw, D. A., A. A. Prestrud, M. R. Somerfield, T. K. Oliver, M. C. Brouwers, R. K. Nam, G. H. Lyman, and E. Basch. 2012. American Society of Clinical Oncology clinical practice guidelines: Formal systematic review-based consensus methodology. Journal of Clinical Oncology 30(25):3136-3140.

MacArthur, D. G., T. A. Manolio, D. P. Dimmock, H. L. Rehm, J. Shendure, G. R. Abecasis, D. R. Adams, R. B. Altman, S. E. Antonarakis, E. A. Ashley, J. C. Barrett, L. G. Biesecker, D. F. Conrad, G. M. Cooper, N. J. Cox, M. J. Daly, M. B. Gerstein, D. B. Goldstein, J. N. Hirschhorn, S. M. Leal, L. A. Pennacchio, J. A. Stamatoyannopoulos, S. R. Sunyaev, D. Valle, B. F. Voight, W. Winckler, and C. Gunter. 2014. Guidelines for investigating causality of sequence variants in human disease. Nature 508(7497):469-476.

Manolio, T. A., R. L. Chisholm, B. Ozenberger, D. M. Roden, M. S. Williams, R. Wilson, D. Bick, E. P. Bottinger, M. H. Brilliant, C. Eng, K. A. Frazer, B. Korf, D. H. Ledbetter, J. R. Lupski, C. Marsh, D. Mrazek, M. F. Murray, P. H. O’Donnell, D. J. Rader, M. V. Relling, A. R. Shuldiner, D. Valle, R. Weinshilboum, E. D. Green, and G. S. Ginsburg. 2013. Implementing genomic medicine in the clinic: the future is here. Genetics in Medicine 15(4):258-267.

Manrai, A. K., B. H. Funke, H. L. Rehm, M. S. Olesen, B. A. Maron, P. Szolovits, D. M. Margulies, J. Loscalzo, and I. S. Kohane. 2016. Genetic misdiagnoses and the potential for health disparities. New England Journal of Medicine 375(7):655-665.

Mardis, E. R. 2008. Next-generation DNA sequencing methods. Annual Review of Genomics and Human Genetics 9:387-402.

Marian, A. J. 2014. Causality in genetics: The gradient of genetic effects and back to Koch’s postulates of causality. Circulation Research 114(2):e18-e21.

Marx, V. 2013. Next-generation sequencing: The genome jigsaw. Nature 501(7466):263-268.

Maurano, M. T., R. Humbert, E. Rynes, R. E. Thurman, E. Haugen, H. Wang, A. P. Reynolds, R. Sandstrom, H. Qu, J. Brody, A. Shafer, F. Neri, K. Lee, T. Kutyavin, S. Stehling-Sun, A. K. Johnson, T. K. Canfield, E. Giste, M. Diegel, D. Bates, R. S. Hansen, S. Neph, P. J. Sabo, S. Heimfeld, A. Raubitschek, S. Ziegler, C. Cotsapas, N. Sotoodehnia, I. Glass, S. R. Sunyaev, R. Kaul, and J. A. Stamatoyannopoulos. 2012. Systematic localization of common disease-associated variation in regulatory DNA. Science 337(6099):1190-1195.

Mayo Clinic. n.d. Autosomal recessive inheritance pattern. http://www.mayoclinic.org/autosomalrecessive-inheritance-pattern/img-20007457 (accessed December 10, 2016).

McCullough, L. B., N. L. Wilson, T. A. Teasdale, A. L. Kolpakchi, and J. R. Skelly. 1993. Mapping personal, familial, and professional values in long-term care decisions. Gerontologist 33(3):324-332.

McEwen, J. E., J. T. Boyer, and K. Y. Sun. 2013. Evolving approaches to the ethical management of genomic data. Trends in Genetics 29(6):375-382.

McGee, T. L., M. Devoto, J. Ott, E. L. Berson, and T. P. Dryja. 1997. Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. American Journal of Human Genetics 61(5):1059-1066.

McGuire, A. L., S. Joffe, B. A. Koenig, B. B. Biesecker, L. B. McCullough, J. S. Blumenthal-Barby, T. Caulfield, S. F. Terry, and R. C. Green. 2013. Point-counterpoint. Ethics and genomic incidental findings. Science 340(6136):1047-1048.

McLaughlin, H. M., O. Ceyhan-Birsoy, K. D. Christensen, I. S. Kohane, J. Krier, W. J. Lane, D. Lautenbach, M. S. Lebo, K. Machini, C. A. MacRae, D. R. Azzariti, M. F. Murray, C. E. Seidman, J. L. Vassy, R. C. Green, H. L. Rehm, and P. MedSeq. 2014. A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Medical Genetics 15:134.

Meckley, L. M., and P. J. Neumann. 2010. Personalized medicine: Factors influencing reimbursement. Health Policy 94(2):91-100.

Mendel, G. 1866. Experiments in plant hybridization, Verhandlungen des naturforschenden Vereines in Brüru. In Verhandlungen des naturforschenden Ver-eines in Brünn, Bd. IV für das Jahr 1865. Abhand-lungen. Pp. 3-47.

MHS (Military Health System). n.d. Karen S. Guice, M.D., M.P.P.: Acting Assistant Secretary of Defense for Health Affairs. www.health.mil/About-MHS/Leadership-Biographies/Karen-S-Guice-MD-MPP (accessed November 2, 2016).

Miller, N. A., E. G. Farrow, M. Gibson, L. K. Willig, G. Twist, B. Yoo, T. Marrs, S. Corder, L. Krivohlavek, A. Walter, J. E. Petrikin, C. J. Saunders, I. Thiffault, S. E. Soden, L. D. Smith, D. L. Dinwiddie, S. Herd, J. A. Cakici, S. Catreux, M. Ruehle, and S. F. Kingsmore. 2015. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Medicine 7:100.

Mills, E. J., S. Kanters, K. Thorlund, A. Chaimani, A. A. Veroniki, and J. P. Ioannidis. 2013. The effects of excluding treatments from network meta-analyses: survey. British Medical Journal 347:f5195.

Minikel, E. V., S. M. Vallabh, M. Lek, K. Estrada, K. E. Samocha, J. F. Sathirapongsasuti, C. Y. McLean, J. Y. Tung, L. P. Yu, P. Gambetti, J. Blevins, S. Zhang, Y. Cohen, W. Chen, M. Yamada, T. Hamaguchi, N. Sanjo, H. Mizusawa, Y. Nakamura, T. Kitamoto, S. J. Collins, A. Boyd, R. G. Will, R. Knight, C. Ponto, I. Zerr, T. F. Kraus, S. Eigenbrod, A. Giese, M. Calero, J. de Pedro-Cuesta, S. Haik, J. L. Laplanche, E. Bouaziz-Amar, J. P. Brandel, S. Capellari, P. Parchi, A. Poleggi, A. Ladogana, A. H. O’Donnell-Luria, K. J. Karczewski, J. L. Marshall, M. Boehnke, M. Laakso, K. L. Mohlke, A. Kahler, K. Chambert, S. McCarroll, P. F. Sullivan, C. M. Hultman, S. M. Purcell, P. Sklar, S. J. van der Lee, A. Rozemuller, C. Jansen, A. Hofman, R. Kraaij, J. G. van Rooij, M. A. Ikram, A. G. Uitterlinden, C. M. van Duijn, C. Exome Aggregation, M. J. Daly, and D. G. MacArthur. 2016. Quantifying prion disease penetrance using large population control cohorts. Science Translational Medicine 8(322):322ra329.

Morrison, A., and R. Boudreau. 2012. Evaluation frameworks for genetic tests. Environmental Scan (37). Ottowa: Canadian Agency for Drugs and Technologies in Health.

Moslehi, R., W. Chu, B. Karlan, D. Fishman, H. Risch, A. Fields, D. Smotkin, Y. Ben-David, J. Rosenblatt, D. Russo, P. Schwartz, N. Tung, E. Warner, B. Rosen, J. Friedman, J.-S. Brunet, and S. A. Narod. 2000. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. American Journal of Human Genetics 66(4):1259-1272.

Moyer, V. A. 2014. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer women: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 160(4):271-281.

Murad, M. H., and V. M. Montori. 2013. Synthesizing evidence: Shifting the focus from individual studies to the body of evidence. Journal of the American Medical Association 309(21):2217-2218.

Murad, M. H., V. M. Montori, J. P. Ioannidis, R. Jaeschke, P. J. Devereaux, K. Prasad, I. Neumann, A. Carrasco-Labra, T. Agoritsas, R. Hatala, M. O. Meade, P. Wyer, D. J. Cook, and G. Guyatt. 2014. How to read a systematic review and meta-analysis and apply the results to patient care: Users’ guides to the medical literature. Journal of the American Medical Association 312(2):171-179.

Napolitano, C., V. Novelli, M. D. Francis, and S. G. Priori. 2015. Genetic modulators of the phenotype in the long QT syndrome: State of the art and clinical impact. Current Opinion in Genetics & Development 33:17-24.

NASEM (National Academies of Sciences, Engineering, and Medicine). 2016. Biomarker tests for molecularly targeted therapies: Key to unlocking precision medicine. Washington, DC: The National Academies Press.

Natarajan, P., N. B. Gold, A. G. Bick, H. McLaughlin, P. Kraft, H. L. Rehm, G. M. Peloso, J. G. Wilson, A. Correa, J. G. Seidman, C. E. Seidman, S. Kathiresan, and R. C. Green. 2016. Aggregate penetrance of genomic variants for actionable disorders in European and African Americans. Science Translational Medicine 8(364):364ra151.

NCBI (National Center for Biotechnology Information). 2016. MedGen Summary of professional guidelines. National Library of Medicine, National Institutes of Health, Department of Health and Human Services. https://www.ncbi.nlm.nih.gov/medgen/docs/guideline (accessed August 9, 2016).

NCBI. 2017. Genetic Testing Registry. National Library of Medicine, National Institutes of Health, Department of Health and Human Services. https://www.ncbi.nlm.nih.gov/gtr (accessed January 31, 2017).

NHGRI. 2016a. IGNITE: Implementing genomics in practice. National Institutes of Health, Department of Health and Human Services. https://www.genome.gov/27554264/implementing-genomics-in-practice-ignite (accessed November 9, 2016).

NHGRI. 2016b. Chromosome abnormalities. National Institutes of Health, Department of Health and Human Services. https://www.genome.gov/11508982/chromosome-abnormalities-fact-sheet (accessed November 9, 2016)

NHGRI. 2017. Clinical Sequencing Exploratory Research (CSER). National Institutes of Health, Department of Health and Human Services. https://www.genome.gov/27546194/clinical-sequencing-exploratory-research (accessed February 16, 2017).

NICE (National Institute for Health and Care Excellence). 2013. Guide to the methods of technology appraisal 2013. https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781 (accessed February 16, 2017).

NIH (National Institutes of Health). 2016. Help me understand genetics. Lister Hill National Center for Biomedical Communications, U.S. National Library of Medicine. https://ghr.nlm.nih.gov/primer (accessed May 25, 2016).

NIST (National Institute of Standards and Technology). 2016. Genome in a Bottle Consortium. https://www.nist.gov/programs-projects/genome-bottle (accessed August 18, 2016).

NLM (National Library of Medicine). 2016. Genetics home reference: Genetic testing. National Institutes of Health, Department of Health and Human Services. November 1.

NLM. n.d. The Francis Crick papers: The discovery of the double helix, 1951-1953. National Institutes of Health, Department of Health and Human Services. https://profiles.nlm.nih.gov/ps/retrieve/Narrative/SC/p-nid/143 (accessed September 27, 2016).

NRC (National Research Council). 1988. Mapping and sequencing the human genome. Washington, DC: National Academy Press.

NSGC (National Society of Genetic Counselors Practice Guidelines Committee). 2015. NSGC evidence-based clinical practice guideline development manual (a living document). April 16, 2015. http://nsgc.org/d/do/6102 (accessed March 28, 2016).

Nussbaum, R. L., R. R. McInnes, and H. F. Willard. 2016. Thompson & Thompson Genetics in Medicine. Philadelphia, PA: Elsevier Inc.

OMIM (Online Mendelian Inheritance in Man). 2015. Achondroplasia; ACH. MIM Number: 100800: March 2, 2015. Baltimore, MD: Johns Hopkins University. http://omim.org (accessed November 9, 2016).

OMIM. 2016a. Sickle cell anemia. MIM Number: 603903: October 18, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/603903 (accessed November 9, 2016).

OMIM. 2016b. Cystic fibrosis transmembrane conductance regulator; CFTR. MIM Number: 602421: November 1, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/602421 (accessed November 9, 2016).

OMIM. 2016c. Huntington disease; HD. MIM Number: 143100: September 14, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/143100 (accessed November 9, 2016).

OMIM. 2016d. Retinis pigmentosa; RP. MIM Number: 268000: September 20, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/268000 (accessed November 9, 2016).

OMIM. 2016e. Fibroblast growth factor receptor 3; FGFR3. MIM Number: 134934: July 20, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/134934 (accessed November 9, 2016).

OMIM. 2016f. Breast cancer 1 gene; BRCA1. MIM Number: 113705: June 23, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/113705 (accessed November 9, 2016).

OMIM. 2016g. Neurofibromatosis, Type I; NF1. MIM Number: 162200: August 18, 2016 Baltimore, MD: Johns Hopkins University. http://omim.org/162200 (accessed November 9, 2016).

OMIM. 2016h. Neurofibromin 1; NF1. MIM Number: 613113: August 4, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/613113 (accessed November 9, 2016).

OMIM. 2016i. Cystic fibrosis; CF. MIM Number: 219700: July 6, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/219700 (accessed November 9, 2016).

OMIM. 2016j. Cardiomyopathy, familial hypertrophic, 1; CMH1. MIM Number: 192600: July 21, 2016. Baltimore, MD: Johns Hopkins University. http://omim.org/192600 (accessed January 31, 2017).

OMIM. 2017. Online Mendelian Inheritance in Man: An online catalog of human genes and genetic disorders. McKusick-Nathans Institute of Genetic Medicine, Baltimore, MD: Johns Hopkins University. http://omim.org (accessed January 31, 2017).

Owens, D. K., E. P. Whitlock, J. Henderson, M. P. Pignone, A. H. Krist, K. Bibbins-Domingo, S. J. Curry, K. W. Davidson, M. Ebell, M. W. Gillman, D. C. Grossman, A. R. Kemper, A. E. Kurth, M. Maciosek, A. L. Siu, and M. L. LeFevre. 2016. Use of decision models in the development of evidence-based clinical preventive services recommendations: Methods of the U.S. Preventive Services Task Force. Annals of Internal Medicine 165(7):501-508.

Pagon, R. A. 2006. GeneTests: An online genetic information resource for health care providers. Journal of the Medical Library Association 94(3):343-348.

Palmetto GBA. 2015. Clinical Test Evaluation Process (CTEP) M00096. http://www.palmettogba.com/Palmetto/Moldx.Nsf/files/MolDX_Clinical_Test_Evaluation_Process_(CTEP)_M00096.pdf/$File/MolDX_Clinical_Test_Evaluation_Process_(CTEP)_M00096.pdf (accessed February 16, 2017).

Palmetto GBA. 2016. MolDX excluded test list (M00047, V14). http://www.palmettogba.com/palmetto/MolDX.nsf/DocsCat/MolDx%20Website~MolDx~Browse%20By%20Topic~Excluded%20Tests~9E8NBK5152?open (accessed April 12, 2016).

Palmetto GBA. n.d. MolDX CTEP: Analytical and Clinical Validation Guidelines (M00012, V3.2, Table 1. Analytical and Clinical Validation Summary. http://www.palmettogba.com/Palmetto/Moldx.Nsf/files/MolDX_CTEP-Analytical_and_Clinical_Validation_Guidelines_(M00012).pdf/$File/MolDX_CTEP-Analytical_and_Clinical_Validation_Guidelines_(M00012).pdf (accessed December 21, 2016).

Pastores, G. M., and D. A. Hughes. 2000. Gaucher disease [Updated February 26, 2015]. In GeneReviews^®, edited by R. A. Pagon, M. P. Adam, H. H. Ardinger, S. E. Wallace, A. Amemiya, L. J. H. Bean, T. D. Bird, N. Ledbetter, H. C. Mefford, R. J. H. Smith, and K. Stephens. Seattle, WA: University of Washington; 1993-2016. https://www.ncbi.nlm.nih.gov/books/NBK1269 (accessed January 31, 2017).

PCORI (Patient-Centered Outcomes Research Institute). 2015. Genetic test results: Putting parents and doctors on the same page. http://www.pcori.org/research-in-action/genetic-test-results-putting-parents-and-doctors-same-page (accessed November 9, 2016).

Philippakis, A. A., D. R. Azzariti, S. Beltran, A. J. Brookes, C. A. Brownstein, M. Brudno, H. G. Brunner, O. J. Buske, K. Carey, C. Doll, S. Dumitriu, S. O. Dyke, J. T. den Dunnen, H. V. Firth, R. A. Gibbs, M. Girdea, M. Gonzalez, M. A. Haendel, A. Hamosh, I. A. Holm, L. Huang, M. E. Hurles, B. Hutton, J. B. Krier, A. Misyura, C. J. Mungall, J. Paschall, B. Paten, P. N. Robinson, F. Schiettecatte, N. L. Sobreira, G. J. Swaminathan, P. E. Taschner, S. F. Terry, N. L. Washington, S. Zuchner, K. M. Boycott, and H. L. Rehm. 2015. The Matchmaker Exchange: A platform for rare disease gene discovery. Human Mutation 36(10):915-921.

Phillips, K. A., J. A. Sakowski, J. Trosman, M. P. Douglas, S. Y. Liang, and P. Neumann. 2014. The economic value of personalized medicine tests: What we know and what we need to know. Genetics in Medicine 16(3):251-257.

Pirmohamed, M., G. Burnside, N. Eriksson, A. L. Jorgensen, C. H. Toh, T. Nicholson, P. Kesteven, C. Christersson, B. Wahlstrom, C. Stafberg, J. E. Zhang, J. B. Leathart, H. Kohnke, A. H. Maitland-van der Zee, P. R. Williamson, A. K. Daly, P. Avery, F. Kamali, and M. Wadelius. 2013. A randomized trial of genotype-guided dosing of warfarin. New England Journal of Medicine 369(24):2294-2303.

Popejoy, A. B., and S. M. Fullerton. 2016. Genomics is failing on diversity. Nature 538(7624):161-164.

Puliti, A., G. Caridi, R. Ravazzolo, and G. M. Ghiggeri. 2007. Teaching molecular genetics: Chapter 4-positional cloning of genetic disorders. Pediatric Nephrology 22(12):2023-2029.

Rehm, H. L. 2013. Disease-targeted sequencing: A cornerstone in the clinic. Naure Reviews Genetics 14(4):295-300.

Rehm, H. L., S. J. Bale, P. Bayrak-Toydemir, J. S. Berg, K. K. Brown, J. L. Deignan, M. J. Friez, B. H. Funke, M. R. Hegde, and E. Lyon. 2013. ACMG clinical laboratory standards for next-generation sequencing. Genetics in Medicine 15(9):733-747.

Rehm, H. L., J. S. Berg, L. D. Brooks, C. D. Bustamante, J. P. Evans, M. J. Landrum, D. H. Ledbetter, D. R. Maglott, C. L. Martin, R. L. Nussbaum, S. E. Plon, E. M. Ramos, S. T. Sherry, M. S. Watson, and ClinGen. 2015. ClinGen—The Clinical Genome Resource. New England Journal of Medicine 372(23):2235-2242.

Rex, D. K., D. A. Johnson, J. C. Anderson, P. S. Schoenfeld, C. A. Burke, and J. M. Inadomi. 2009. American College of Gastroenterology guidelines for colorectal cancer screening 2009. American Journal of Gastroenterology 104(3):739-750.

Richards, S., N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W. W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, H. L. Rehm, and A. L. Q. A. Committee. 2015. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine 17(5):405-424.

Rivolta, C., D. Sharon, M. M. DeAngelis, and T. P. Dryja. 2002. Retinitis pigmentosa and allied diseases: Numerous diseases, genes, and inheritance patterns. Human Molecular Genetics 11(10):1219-1227.

Rogowski, W. H., S. D. Grosse, J. John, H. Kaariainen, A. Kent, U. Kristofferson, and J. Schmidtke. 2010. Points to consider in assessing and appraising predictive genetic tests. Journal of Community Genetics 1(4):185-194.

Ross, L. F., H. M. Saal, K. L. David, R. R. Anderson, American Academy of Pediatrics, and American College of Medical Genetics and Genomics. 2013. Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine 15(3):234-245.

Rousseau, F., C. Lindsay, M. Charland, Y. Labelle, J. Bergeron, I. Blancquaert, R. Delage, B. Gilfix, M. Miron, G. A. Mitchell, L. Oligny, M. Pazzagli, C. Mamotte, D. Payne, and IFCC Scientific Division Committee on Molecular Diagnostics. 2010. Development and description of GETT: A genetic testing evidence tracking tool. Clinical Chemistry and Laboratory Medicine 48(10):1397-1407.

Rubinstein, W. S., D. R. Maglott, J. M. Lee, B. L. Kattman, A. J. Malheiro, M. Ovetsky, V. Hem, V. Gorelenkov, G. Song, C. Wallin, N. Husain, S. Chitipiralla, K. S. Katz, D. Hoffman, W. Jang, M. Johnson, F. Karmanov, A. Ukrainchik, M. Denisenko, C. Fomous, K. Hudson, and J. M. Ostell. 2013. The NIH genetic testing registry: A new, centralized database of genetic tests to enable access to comprehensive information and improve transparency. Nucleic Acids Research 41(Database issue):D925-D935.

Samuels, M. E., A. Orr, D. L. Guernsey, K. Dooley, C. Riddell, K. Hodgkinson, M. Ludman, and D. Pullman. 2008. Is gene discovery research or diagnosis? Genetics in Medicine 10(6):385-390.

Sanderson, S., R. Zimmern, M. Kroese, J. Higgins, C. Patch, and J. Emery. 2005. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine 7(7):495-500.

Sawaya, G. F., J. Guirguis-Blake, M. LeFevre, R. Harris, D. Petitti, and US Preventive Services Task Force. 2007. Update on the methods of the U.S. Preventive Services Task Force: Estimating certainty and magnitude of net benefit. Annals of Internal Medicine 147(12):871-875.

Schatzberg, A. F., C. DeBattista, L. C. Lazzeroni, A. Etkin, G. M. Murphy, Jr., and L. M. Williams. 2015. ABCB1 genetic effects on antidepressant outcomes: A report from the iSPOT-D trial. American Journal of Psychiatry 172(8):751-759.

Schelleman, H., N. A. Limdi, and S. E. Kimmel. 2008. Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics. Pharmacogenomics 9(9):1331-1346.

Schott, S., E. Edelman, T. Imgram, and K. Reed. 2015. Genetic testing methods. The Jackson Laboratory. https://www.jax.org/~/media/jaxweb/files/education-and-learning/ccep/genetictestingmethodsresourcepdf_v1.pdf?la=en (accessed November 9, 2016).

Schunemann, H. J., R. Mustafa, J. Brozek, N. Santesso, P. Alonso-Coello, G. Guyatt, R. Scholten, M. Langendam, M. M. Leeflang, E. A. Akl, J. A. Singh, J. Meerpohl, M. Hultcrantz, P. Bossuyt, A. D. Oxman, and GRADE Working Group. 2016. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. Journal of Clinical Epidemiology 76:89-98.

Simon, R. M., S. Paik, and D. F. Hayes. 2009. Use of archived specimens in evaluation of prognostic and predictive biomarkers. Journal of the National Cancer Institute 101(21):1446-1452.

Siu, A. L., and US Preventive Services Task Force. 2016. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine 164(4):279-296.

Sobreira, N., F. Schiettecatte, D. Valle, and A. Hamosh. 2015. GeneMatcher: A matching tool for connecting investigators with an interest in the same gene. Human Mutation 36(10):928-930.

Sox, H. C., and S. N. Goodman. 2012. The methods of comparative effectiveness research. Annual Review of Public Health 33:425-445.

Stein, R. E., and C. K. Riessman. 1980. The development of an impact-on-family scale: Preliminary findings. Medical Care 18(4):465-472.

Stuckey, H., J. L. Williams, A. L. Fan, A. K. Rahm, J. Green, L. Feldman, M. Bonhag, D. T. Zallen, M. M. Segal, and M. S. Williams. 2015. Enhancing genomic laboratory reports from the patients’ view: A qualitative analysis. American Journal of Medical Genetics Association 167A(10):2238-2243.

Suarez-Kurtz, G., and M. R. Botton. 2013. Pharmacogenomics of warfarin in populations of African descent. British Journal of Clinical Pharmacology 75(2):334-346.

Sullivan, S. D., J. Watkins, B. Sweet, and S. D. Ramsey. 2009. Health technology assessment in healthcare decisions in the United States. Value Health 12(Suppl 2):S39-S44.

Sun, F., W. Bruening, E. Erinoff, and K. M. Schoelles. 2011. AHRQ methods for effective health care. In Addressing Challenges in Genetic Test Evaluation: Evaluation Frameworks and Assessment of Analytic Validity. Rockville, MD: Agency for Healthcare Research and Quality.

Task Force on Genetic Testing. 1997. Chapter 1: Introduction. In Promoting Safe and Effective Genetic Testing in the United States, edited by N. A. Holtzman and M. S. Watson: National Institutes of Health—Department of Energy Working Group on Ethical, Legal and Social Implications of Human Genome Research. https://www.genome.gov/10002405/genetic-testing-reportchapter-1 (accessed November 9, 2016).

Telenti, A., L. C. Pierce, W. H. Biggs, J. di Iulio, E. H. Wong, M. M. Fabani, E. F. Kirkness, A. Moustafa, N. Shah, C. Xie, S. C. Brewerton, N. Bulsara, C. Garner, G. Metzker, E. Sandoval, B. A. Perkins, F. J. Och, Y. Turpaz, and J. C. Venter. 2016. Deep sequencing of 10,000 human genomes. Proceedings of the National Academy of Sciences of the United States of America 113(42):11901-11906.

Teutsch, S. M., L. A. Bradley, G. E. Palomaki, J. E. Haddow, M. Piper, N. Calonge, W. D. Dotson, M. P. Douglas, A. O. Berg, and EGAPP Working Group. 2009. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: Methods of the EGAPP Working Group. Genetics in Medicine 11(1):3-14.

Theisen, A. 2008. Microarray-based Comparative Genomic Hybridization (aCGH). Nature Education 1(1):25.

Trosman, J. R., S. L. Van Bebber, and K. A. Phillips. 2010. Coverage policy development for personalized medicine: Private payer perspectives on developing policy for the 21-gene assay. Journal of Oncology Practice 6(5):238-242.

Trosman, J. R., S. L. Van Bebber, and K. A. Phillips. 2011. Health technology assessment and private payers’ coverage of personalized medicine. Journal of Oncology Practice 7(3 Suppl):18s-24s.

Tunis, S. R., D. B. Stryer, and C. M. Clancy. 2003. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. Journal of the American Medical Association 290(12):1624-32.

Turner, F. 1995. Differential diagnosis & treatment in social work. 4th ed. New York: The Free Press.

Twisk, M., S. Mastenbroek, M. van Wely, M. J. Heineman, F. Van der Veen, and S. Repping. 2006. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews(1):CD005291.

USPSTF (US Preventive Services Task Force). 2013. Grade Definitions: US Preventive Services Task Force.

USPSTF. 2015. Procedure manual. December. https://www.uspreventiveservicestaskforce.org/Home/GetFile/6/7/procedure-manual_2016_v2/pdf (accessed February 16, 2017).

van Dijk, E. L., H. Auger, Y. Jaszczyszyn, and C. Thermes. 2014. Ten years of next-generation sequencing technology. Trends in Genetics 30(9):418-426.

Van Driest, S. L., Q. S. Wells, S. Stallings, W. S. Bush, A. Gordon, D. A. Nickerson, J. H. Kim, D. R. Crosslin, G. P. Jarvik, D. S. Carrell, J. D. Ralston, E. B. Larson, S. J. Bielinski, J. E. Olson, Z. Ye, I. J. Kullo, N. S. Abul-Husn, S. A. Scott, E. Bottinger, B. Almoguera, J. Connolly, R. Chiavacci, H. Hakonarson, L. J. Rasmussen-Torvik, V. Pan, S. D. Persell, M. Smith, R. L. Chisholm, T. E. Kitchner, M. M. He, M. H. Brilliant, J. R. Wallace, K. F. Doheny, M. B. Shoemaker, R. Li, T. A. Manolio, T. E. Callis, D. Macaya, M. S. Williams, D. Carey, J. D. Kapplinger, M. J. Ackerman, M. D. Ritchie, J. C. Denny, and D. M. Roden. 2016. Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. Journal of the American Medical Association 315(1):47-57.

Van Poznak, C., M. R. Somerfield, R. C. Bast, M. Cristofanilli, M. P. Goetz, A. M. Gonzalez-Angulo, D. G. Hicks, E. G. Hill, M. C. Liu, W. Lucas, I. A. Mayer, R. G. Mennel, W. F. Symmans, D. F. Hayes, and L. N. Harris. 2015. Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology 33(24):2695-2704.

Vanstone, M., E. A. Kinsella, and J. Nisker. 2012. Information-sharing to promote informed choice in prenatal screening in the spirit of the SOGC clinical practice guideline: A proposal for an alternative model. Journal of Obstetrics and Gynaecology Canada 34(3):269-275.

Venter, J. C., M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, G. G. Sutton, H. O. Smith, M. Yandell, C. A. Evans, R. A. Holt, J. D. Gocayne, P. Amanatides, R. M. Ballew, D. H. Huson, J. R. Wortman, Q. Zhang, C. D. Kodira, X. H. Zheng, L. Chen, M. Skupski, G. Subramanian, P. D. Thomas, J. Zhang, G. L. Gabor Miklos, C. Nelson, S. Broder, A. G. Clark, J. Nadeau, V. A. McKusick, N. Zinder, A. J. Levine, R. J. Roberts, M. Simon, C. Slayman, M. Hunkapiller, R. Bolanos, A. Delcher, I. Dew, D. Fasulo, M. Flanigan, L. Florea, A. Halpern, S. Hannenhalli, S. Kravitz, S. Levy, C. Mobarry, K. Reinert, K. Remington, J. Abu-Threideh, E. Beasley, K. Biddick, V. Bonazzi, R. Brandon, M. Cargill, I. Chandramouliswaran, R. Charlab, K. Chaturvedi, Z. Deng, V. Di Francesco, P. Dunn, K. Eilbeck, C. Evangelista, A. E. Gabrielian, W. Gan, W. Ge, F. Gong, Z. Gu, P. Guan, T. J. Heiman, M. E. Higgins, R. R. Ji, Z. Ke, K. A. Ketchum, Z. Lai, Y. Lei, Z. Li, J. Li, Y. Liang, X. Lin, F. Lu, G. V. Merkulov, N. Milshina, H. M. Moore, A. K. Naik, V. A. Narayan, B. Neelam, D. Nusskern, D. B. Rusch, S. Salzberg, W. Shao, B. Shue, J. Sun, Z. Wang, A. Wang, X. Wang, J. Wang, M. Wei, R. Wides, C. Xiao, C. Yan, A. Yao, J. Ye, M. Zhan, W. Zhang, H. Zhang, Q. Zhao, L. Zheng, F. Zhong, W. Zhong, S. Zhu, S. Zhao, D. Gilbert, S. Baumhueter, G. Spier, C. Carter, A. Cravchik, T. Woodage, F. Ali, H. An, A. Awe, D. Baldwin, H. Baden, M. Barnstead, I. Barrow, K. Beeson, D. Busam, A. Carver, A. Center, M. L. Cheng, L. Curry, S. Danaher, L. Davenport, R. Desilets, S. Dietz, K. Dodson, L. Doup, S. Ferriera, N. Garg, A. Gluecksmann, B. Hart, J. Haynes, C. Haynes, C. Heiner, S. Hladun, D. Hostin, J. Houck, T. Howland, C. Ibegwam, J. Johnson, F. Kalush, L. Kline, S. Koduru, A. Love, F. Mann, D. May, S. McCawley, T. McIntosh, I. McMullen, M. Moy, L. Moy, B. Murphy, K. Nelson, C. Pfannkoch, E. Pratts, V. Puri, H. Qureshi, M. Reardon, R. Rodriguez, Y. H. Rogers, D. Romblad, B. Ruhfel, R. Scott, C. Sitter, M. Smallwood, E. Stewart, R. Strong, E. Suh, R. Thomas, N. N. Tint, S. Tse, C. Vech, G. Wang, J. Wetter, S. Williams, M. Williams, S. Windsor, E. Winn-Deen, K. Wolfe, J. Zaveri, K. Zaveri, J. F. Abril, R. Guigo, M. J. Campbell, K. V. Sjolander, B. Karlak, A. Kejariwal, H. Mi, B. Lazareva, T. Hatton, A. Narechania, K. Diemer, A. Muruganujan, N. Guo, S. Sato, V. Bafna, S. Istrail, R. Lippert, R. Schwartz, B. Walenz, S. Yooseph, D. Allen, A. Basu, J. Baxendale, L. Blick, M. Caminha, J. Carnes-Stine, P. Caulk, Y. H. Chiang, M. Coyne, C. Dahlke, A. Mays, M. Dombroski, M. Donnelly, D. Ely, S. Esparham, C. Fosler, H. Gire, S. Glanowski, K. Glasser, A. Glodek, M. Gorokhov, K. Graham, B. Gropman, M. Harris, J. Heil, S. Henderson, J. Hoover, D. Jennings, C. Jordan, J. Jordan, J. Kasha, L. Kagan, C. Kraft, A. Levitsky, M. Lewis, X. Liu, J. Lopez, D. Ma, W. Majoros, J. McDaniel, S. Murphy, M. Newman, T. Nguyen, N. Nguyen, M. Nodell, S. Pan, J. Peck, M. Peterson, W. Rowe, R. Sanders, J. Scott, M. Simpson, T. Smith, A. Sprague, T. Stockwell, R. Turner, E. Venter, M. Wang, M. Wen, D. Wu, M. Wu, A. Xia, A. Zandieh, and X. Zhu. 2001. The sequence of the human genome. Science 291(5507):1304-1351.

Wailoo, K. 1999. Drawing blood: Technology and disease identity in twentieth-century America. Baltimore, MD: Johns Hopkins University Press.

Walter, J. H., N. Jahnke, and T. Remmington. 2015. Newborn screening for homocystinuria. Cochrane Database of Systematic Reviews 10(10):CD008840.

Wang, B., W. J. Canestaro, and N. K. Choudhry. 2014. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels. JAMA Internal Medicine 174(12):1938-1944.

Watson, J. D., and F. H. Crick. 1953. Molecular structure of nucleic acids: A structure for deoxyribose nucleic acid. Nature 171(4356):737-738.

Wexler, N. S., J. Lorimer, J. Porter, F. Gomez, C. Moskowitz, E. Shackell, K. Marder, G. Penchaszadeh, S. A. Roberts, J. Gayan, D. Brocklebank, S. S. Cherny, L. R. Cardon, J. Gray, S. R. Dlouhy, S. Wiktorski, M. E. Hodes, P. M. Conneally, J. B. Penney, J. Gusella, J. H. Cha, M. Irizarry, D. Rosas, S. Hersch, Z. Hollingsworth, M. MacDonald, A. B. Young, J. M. Andresen, D. E. Housman, M. M. De Young, E. Bonilla, T. Stillings, A. Negrette, S. R. Snodgrass, M. D. Martinez-Jaurrieta, M. A. Ramos-Arroyo, J. Bickham, J. S. Ramos, F. Marshall, I. Shoulson, G. J. Rey, A. Feigin, N. Arnheim, A. Acevedo-Cruz, L. Acosta, J. Alvir, K. Fischbeck, L. M. Thompson, A. Young, L. Dure, C. J. O’Brien, J. Paulsen, A. Brickman, D. Krch, S. Peery, P. Hogarth, D. S. Higgins, Jr., B. Landwehrmeyer, and US-Venezuela Collaborative Research Project. Project. 2004. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington’s disease age of onset. Proceedings of the National Academy of Sciences of the United States of America 101(10):3498-3503.

Wilfond, B. S., C. V. Fernandez, and R. C. Green. 2015. Disclosing secondary findings from pediatric sequencing to families: Considering the “benefit to families.” Journal of Law, Medicine & Ethics 43(3):552-558.

Wolf, S. M., G. J. Annas, and S. Elias. 2013. Point-counterpoint: Patient autonomy and incidental findings in clinical genomics. Science 340(6136):1049-1050.

Yang, L., W. Ge, F. Yu, and H. Zhu. 2010. Impact of VKORC1 gene polymorphism on interindividual and interethnic warfarin dosage requirement—A systematic review and meta-analysis. Thrombosis Research 125(4):e159-e166.

Zhang, F., W. Gu, M. E. Hurles, and J. R. Lupski. 2009. Copy number variation in human health, disease, and evolution. Annual Review of Genomics and Human Genetics 10:451-481.

Ziogas, A., N. K. Horick, A. Y. Kinney, J. T. Lowery, S. M. Domchek, C. Isaacs, C. A. Griffin, P. G. Moorman, K. L. Edwards, D. A. Hill, J. S. Berg, G. E. Tomlinson, H. Anton-Culver, L. C. Strong, C. H. Kasten, D. M. Finkelstein, and S. E. Plon. 2011. Clinically relevant changes in family history of cancer over time. Journal of the American Medical Association 306(2):172-178.